Home | Business News | Browse by Publication | M | M2 Presswire

www.PicksThatMove.com: "Picks that move" Alerts, July 13, 2009: FLML, ATEC, MENT, SPSS, BMRN and MPET.

Publication: M2 Presswire
Publication Date: 13-JUL-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
M2 PRESSWIRE-13 July 2009-PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, July 13, 2009: FLML, ATEC, MENT, SPSS, BMRN and MPET.(C)1994-2009 M2 COMMUNICATIONS

RDATE:13072009

Picksthatmove.com Alerts include Flamel Technologies, SA (NASDAQ: FLML); Alphatec Holdings, Inc. (Nasdaq: ATEC); Mentor Graphics Corporation (NASDAQ: MENT); SPSS Inc. (Nasdaq: SPSS); BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Magellan Petroleum Corporation (Nasdaq: MPET)

-- July 10, 2009 Flamel Technologies, SA (NASDAQ: FLML) closed at $8.03 on a volume of 44,767 shares.

In a press release out on July 13, 2009 Baxter and Flamel Technologies Announce Collaboration to Formulate Longer Acting Forms of Blood Clotting Factors

DEERFIELD, Ill. & LYON, France, Jul 13, 2009 -- Baxter International Inc. (NYSE: BAX) and Flamel Technologies, SA (NASDAQ: FLML) announced today that they have entered into agreement to formulate controlled release applications of blood clotting factor replacement therapies using Flamel's Medusa(R) Technology. The work between the two companies will focus on developing longer-acting formulations with the objective of reducing the frequency of infusions required to treat blood clotting disorders in hemophilia. Pursuant to the agreement between the two companies, Flamel will receive technology access fees totaling EUR 2.5 million. Baxter will pay all development costs for the program and have an exclusive right to negotiate a license to the Medusa platform.

About Flamel Technologies

Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Flamel's Medusa technology is designed to deliver controlled-release formulations of therapeutic proteins and peptides and other...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from M2 Presswire
(SINA) SqueezeTrigger Price is $27.813. There is $260,675,730.00 That ..., July 13, 2009
WRLS and AVCA Expected To Be Lower Leading Up To Next Earnings Release..., July 13, 2009
STC, FCH, SYMM, AMCS, CRRC, WSTL Expected To Be Lower Leading Up To Ne..., July 13, 2009
EP, FORM, WIT, AHT, BCPC, BCRX Expected To Be Lower Leading Up To Next..., July 13, 2009
Trinidad and Tobago Gas Markets Investment Opportunities, Market Analy..., July 13, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.